Search Results 71-80 of 18284 for total bilirubin

1. A Study To Evaluate The Safety And Effectiveness Of Obeticholic Acid Treatment On People With Non-Alcoholic Steatohepatitis With Fibrosis - Mayo Clinic

   Participation eligibility · Histological presence of cirrhosis. · Total bilirubin >1.5 mg/dL (subjects with Gilbert's syndrome may be enrolled despite a total ...

2. An Extension Study To Assess The Safety Of The Use Of Cannabidiol In Children And Young Adults With Dravet Or Lennox-Gastaut Syndromes - Mayo Clinic

   ... total bilirubin [TBL] >2 x ULN; ALT or aspartate aminotransferase (AST) >3 x ULN and TBL >2 x ULN or international normalized ratio [INR] >1.5; This criterion ...

3. An Open-Label Safety And Tolerability Study Of INCB062079 In Subjects With Advanced Hepatocellular Carcinoma And Other Malignancies - Mayo Clinic

   Serum phosphate above ULN per institution. Part 2 Expansion: Hemoglobin ≤9.0 g/dL; Platelet count ≤75 × 109/L; ANC ≤ 1.0 × 109/L; Total bilirubin ≥ 1.5 × ...

4. A Study Of CIN-107 In Adults With Primary Aldosteronism - Mayo Clinic

   Serum aspartate aminotransferase or alanine aminotransferase > 3 upper limit of normal (ULN);; Total bilirubin >2 ULN, unless due to Gilbert's syndrome. Has ...

5. Study To Evaluate The Efficacy And Safety Of Elafibranor In Patients With Primary Biliary Cholangitis (PBC) And Inadequate Response To Ursodeoxycholic Acid - Mayo Clinic

   Gilbert's Syndrome (due to interpretability of bilirubin levels); Screening CPK > ULN; Screening ALT or AST > 5 ULN; Screening total bilirubin > 2 ULN ...

6. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Total bilirubin =< 1.5 x upper limit of normal (ULN) (=< 28 days prior to registration); (Isolated bilirubin >= 1.5 x ULN is acceptable if bilirubin is ...

7. A Study To Evaluate Gemcitabine And MK-3475 (Pembrolizumab) To Treat Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Total Bilirubin ≤ 1.5 x ULN. In patients with a total bilirubin > 1.5 x ULN, if direct bilirubin < 1.0 X ULN, then patient is eligible. Aspartate ...

8. Combination Chemotherapy With Or Without Blinatumomab In Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia - Mayo Clinic

   Serum direct bilirubin < 2 mg/dl or serum total bilirubin ≤ 3; NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction ...

9. A Study Of Ramucirumab (LY3009806) In Children And Young Adults With Synovial Sarcoma - Mayo Clinic

   Total bilirubin: ≤ 1.5 × ULN. Except participants with document history of Gilbert Syndrome who must have a total bilirubin level of <3.0 × LN. Alanine ...

10. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN) (except patients with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL). Aspartate ...